SCHEMBL21725399

SCHEMBL21725399

c1ccc(-c2cccc(-c3nc(-c4ccc(-c5ccc(-c6ccc[nH]6)cc5)cc4)cc(-c4cc5ccccc5c5ccccc45)n3)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
ALDH1A1 P00352 3/20 0.41
MAPT P10636 3/20 0.41
HPGD P15428 3/20 0.41
KDM4E B2RXH2 2/20 0.41
LMNA P02545 2/20 0.41
GLA P06280 1/20 0.39
ADORA2A P29274 1/20 0.38
NTSR1 P30989 1/20 0.37
CYP11B1 P15538 1/20 0.35
CYP1A1 P04798 1/20 0.35
CYP1B1 Q16678 1/20 0.35
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
ACACA Q13085 1/20 0.33
AURKA O14965 1/20 0.33
PDPK1 O15530 1/20 0.33
TGFBR1 P36897 1/20 0.33
AURKB Q96GD4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19650545 0.94 CYP1A1 (0.40) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21725416 0.94 MEN1 (0.42) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL19650645 0.92 MEN1 (0.36) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL24767420 0.91 MEN1 (0.36) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL19650660 0.89 ADORA2A (0.36) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL19650638 0.89 ADORA2A (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL19650632 0.86 ENPP3 (0.36) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL19650544 0.86 MEN1 (0.40) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL19650618 0.86 ADORA2A (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL19650630 0.85 MEN1 (0.45) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10566543-B2 Pyrimidine derivative and organic electroluminescent devices HODOGAYA CHEMICAL CO., LTD. (JP) 2020-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10566543-B2 Pyrimidine derivative and organic electroluminescent devices TYMS, TYMP, DPYD MEN1 4184/4885KMT2A 3609/4885ALDH1A1 582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.